Dr. Bhatt serves as the Executive Director of Interventional Cardiovascular Programs at Harvard Medical School, affiliated Brigham and Women’s Hospital, and as a Professor at Harvard Medical School. He is the Editor of the Journal of Invasive Cardiology and the Editor-in-Chief of the Harvard Heart Letter for patients. View Biography >>
Paresh N. Soni, M.D., Ph.D., Member, SAB
Dr. Soni brings 20+ years of experience leading multidisciplinary teams across the entire drug development spectrum. As Head of Development at Amarin, Dr. Soni led the clinical trial and regulatory strategy for Amarin’s natural product fish oil drug Vascepa. View Biography >>
R. Preston Mason, Ph.D., Member, SAB
Dr. Mason serves on the Faculty of the Department of Medicine, Division of Cardiology, at Harvard Medical School, affiliated Brigham and Women’s Hospital. He has published more than 250 peer reviewed papers, including papers published in collaboration with Cardax, and is a recognized expert on the mechanism of action of astaxanthin and fish oils, particularly Vascepa. View Biography >>
Gilbert M. Rishton, Ph.D., Member, SAB
Served previously as Cardax Chief Science Officer. Former drug discovery and development leader at Amgen. Built Amgen’s Small Molecule Drug Discovery Group, managed chemistry for preclinical and clinical development of Sensipar, and led medicinal chemistry for Amgen’s Secretase Team. Founder and Director of the Channel Islands Alzheimer’s Institute. View Biography >>
Jon L. Ruckle, M.D., Member, SAB
Served previously as Cardax Chief Medical Officer. Principal investigator of more than 350 clinical trials. Former Medical Director at Covance. View Biography >>
Timothy J. King, Ph.D., Member, SAB
Served previously as Cardax Vice President, Research. Over 25 years of combined academic and private sector scientific research conducting biomedical research utilizing cell culture and genetically-engineered mouse model systems. Formerly a Staff Scientist at the Fred Hutchinson Cancer Research Center. View Biography >>
A. David Hieber, Ph.D., Member, SAB
Served previously as Cardax Associate Director, Biology. Over fifteen years of experience exploring the effects of carotenoids on human health and disease, xanthophylls in plant photoprotection, and biosynthesis of carotenoids in plants and algae. View Biography >>
Henry L. Jackson, Ph.D., Member, SAB
Served previously as Cardax Associate Director, Chemistry. Over fifteen years of experience as a medicinal chemist. Skilled in the total synthesis of rare xanthophylls and co-inventor on several composition of matter patents. View Biography >>